Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sensi

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Acta Diabetologica Latina|April 1, 1980
The importance of measuring Fc+ (killer) cells in insulin-dependent (type 1) diabetesP Pozzilli, M Sensi, B Dean, et al.
Tumori|August 31, 1989
Loss of heterozygosity of DQ alpha gene in human malignant melanomaC Castelli, F Mazzucchelli, M Sensi, et al.
Clinical and Experimental Immunology|July 1, 1982
Histology of the islets of Langerhans following administration of human lymphocytes into athymic miceM Sensi, P Pozzilli, L Ventriglia, et al.
Biomedica Biochimica Acta|January 1, 1984
Cell-mediated immunity in the aetiopathogenesis of insulin-dependent (type I) diabetes mellitusP Pozzilli, O Zuccarini, M Sensi, et al.
Biochimica Et Biophysica Acta|July 8, 1987
Treatment of a low immunogenic experimental tumour with alloactivated or tumour-immune lymphocytesG Parmiani, L Grazioli, M Sensi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 4, 1998
Intralesional selection of T cell clonotypes in the immune response to melanoma antigens occurring during vaccinationM Sensi, C Farina, C Maccalli, et al.
Lancet (London, England)|July 28, 1979
Evidence for raised K-cell levels in type-I diabetesP Pozzilli, M Sensi, A Gorsuch, et al.
International Immunology|September 1, 1996
Conserved TCR usage by HLA-Cw* 1601-restricted T cell clones recognizing melanoma antigensC Farina, P van der Bruggen, P Boël, et al.
Tissue Antigens|July 24, 2002
Identification of a novel gp100/pMel17 peptide presented by HLA-A*6801 and recognized on human melanoma by cytolytic T cell clonesM Sensi, S Pellegatta, C Vegetti, et al.
Melanoma Research|February 1, 1994
N-RAS mutations and susceptibility to lymphokine-activated killer (LAK) cells in human melanomaR Lupetti, M Sensi, R Mortarini, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Acta Diabetologica Latina|April 1, 1980
The importance of measuring Fc+ (killer) cells in insulin-dependent (type 1) diabetesP Pozzilli, M Sensi, B Dean, et al.
Tumori|August 31, 1989
Loss of heterozygosity of DQ alpha gene in human malignant melanomaC Castelli, F Mazzucchelli, M Sensi, et al.
Clinical and Experimental Immunology|July 1, 1982
Histology of the islets of Langerhans following administration of human lymphocytes into athymic miceM Sensi, P Pozzilli, L Ventriglia, et al.
Biomedica Biochimica Acta|January 1, 1984
Cell-mediated immunity in the aetiopathogenesis of insulin-dependent (type I) diabetes mellitusP Pozzilli, O Zuccarini, M Sensi, et al.
Biochimica Et Biophysica Acta|July 8, 1987
Treatment of a low immunogenic experimental tumour with alloactivated or tumour-immune lymphocytesG Parmiani, L Grazioli, M Sensi, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 4, 1998
Intralesional selection of T cell clonotypes in the immune response to melanoma antigens occurring during vaccinationM Sensi, C Farina, C Maccalli, et al.
Lancet (London, England)|July 28, 1979
Evidence for raised K-cell levels in type-I diabetesP Pozzilli, M Sensi, A Gorsuch, et al.
International Immunology|September 1, 1996
Conserved TCR usage by HLA-Cw* 1601-restricted T cell clones recognizing melanoma antigensC Farina, P van der Bruggen, P Boël, et al.
Tissue Antigens|July 24, 2002
Identification of a novel gp100/pMel17 peptide presented by HLA-A*6801 and recognized on human melanoma by cytolytic T cell clonesM Sensi, S Pellegatta, C Vegetti, et al.
Melanoma Research|February 1, 1994
N-RAS mutations and susceptibility to lymphokine-activated killer (LAK) cells in human melanomaR Lupetti, M Sensi, R Mortarini, et al.
Pageof 11